STETZ GARY S. (Chief Executive Officer) purchased 1.25M shares of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $50.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/27/2026ACC: 0001493152-26-019027
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+1.25M
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.25M acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Indirect
Shares
+1.25M
Price / share
$0.04
Trade value
$50K
% of position
New position
4/21/2026
0.00→1.25M
Total
Net shares
+1.25M
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 4/21/2026 | P · Purchase | +1.25M | $0.04 | $50K | New position | 0.00 | 1.25M |
| Total | +1.25M | $50K | ||||||
Derivative Transactions0
No derivative transactions reported